W
WAVEMAN · COMPANY
CSW · Csw Industrials, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

CSW

CSW INDUSTRIALS, INC.
PHARMA & BIOTECH · ADHESIVES & SEALANTS · CIK 0001624794
CONGRESS · 2FORM 144 · 4☆ WATCH
INSIDER NET · 180D
-$5.0M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
1
CONGRESS BUYERS · 1Y
2
FUNDS ADDED · QTR
164
13F, latest reported quarter
REVENUE GROWTH
+23.3%
XBRL, annual
NET MARGIN
10.4%
CONVERSIONS · 180D
8
codes C/M, not in net · $0 priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$5.0M over 180 days
-$3.2M over 90 days
below 78% of Pharma & Biotech
CONGRESS
2 members bought in the last year
more than 65% of Pharma & Biotech
FUNDS
164 funds added or opened last quarter
more than 81% of Pharma & Biotech
REVENUE
+23.3% year over year
more than 71% of Pharma & Biotech
MARGIN
10.4% net margin
more than 81% of Pharma & Biotech
BUYBACKS
$36.3M repurchased, FY to 2026-06-30
more than 51% of Pharma & Biotech
SHORT
7.9% of shares outstanding short · 7.0 days to cover · settled 2026-07-31
more than 68% of Pharma & Biotech
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$5.0M across 4 people in 180 days.
164 funds added or opened positions in the latest 13F quarter, of 357 holders.
2 members of Congress reported buying it this year.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +15.1%
+15.1%12M
-13%+2%+17%+32%2025-092025-102025-122026-032026-052026-072026-09 2026-08-05 · Sullivan Don sold $1.6M2025-12-08 · Sullivan Don sold $1.2M2026-08-14 · Armes Joseph B sold $517.7K2026-02-17 · Armes Joseph B sold $446.7K2026-07-15 · Armes Joseph B sold $434.9K2026-04-15 · Armes Joseph B sold $430.2K2026-05-27 · Armes Joseph B sold $425.9K2026-06-15 · Armes Joseph B sold $419.3K2026-03-23 · Armes Joseph B sold $405.2K2026-01-15 · Armes Joseph B sold $328.6K2025-12-15 · Armes Joseph B sold $317.4K2026-05-01 · Alverson Luke sold $291.6K2026-04-07 · Alverson Luke sold $268.0K2025-11-14 · Armes Joseph B sold $250.0K2025-10-30 · Armes Joseph B sold $250.0K2025-09-15 · Armes Joseph B sold $250.0K2026-08-10 · UNDERWOOD JEFF sold $249.8K2025-12-01 · Perry James E sold $159.5K2026-02-11 · Alverson Luke sold $158.0K2025-12-02 · UNDERWOOD JEFF sold $103.2K2025-11-18 · WANG FANG sold $86.4K2026-03-13 · Ash Darron K bought $77.0K2025-12-02 · Alverson Luke sold $76.4K2026-04-15 · Sullivan Don sold $49.8K2026-01-02 · Perry James E sold $42.6K2026-08-14 · Armes Joseph B filed to sell $517.7K2026-08-10 · Jeffrey Underwood filed to sell $249.8K2026-08-05 · Donal Sullivan filed to sell $1.6M2026-07-15 · Armes Joseph B filed to sell $434.9K
INSIDER BUYINSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $5.0M sold by insiders over 180 days, 164 funds added last quarter, 2 Congress member(s) bought in 12 months, $2.8M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
UTHRCPIXMRNAREGNLLYALNYELFCITRMDGLDNAVRTXNUVL
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, CSW INDUSTRIALS, INC. insiders sold a net $5.0M of stock across 39 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Armes Joseph B
Chairman, President & CEO
SELL
2026-08-14
1,500.0
$517.7K
UNDERWOOD JEFF
EVP, GM Contractor Solutions
SELL
2026-08-10
720.0
$249.8K
Sullivan Don
EVP, Chief Strategy Officer
SELL
2026-08-05
4,526.0
$1.6M
Armes Joseph B
Chairman, President & CEO
SELL
2026-07-15
1,500.0
$434.9K
Armes Joseph B
Chairman, President & CEO
SELL
2026-06-15
1,500.0
$419.3K
39 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 34 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BlackRock, Inc.
2,466,624.0 sh
$686.5M
VANGUARD PORTFOLIO MANAGEMENT LLC
888,596.0 sh
$247.3M
Capital World Investors
746,545.0 sh
$207.8M
VANGUARD CAPITAL MANAGEMENT LLC
736,304.0 sh
$204.9M
WASATCH ADVISORS LP
693,036.0 sh
$192.9M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
Armes Joseph B
FILED 2026-08-14
$517.7K
Jeffrey Underwood
FILED 2026-08-10
$249.8K
Donal Sullivan
FILED 2026-08-05
$1.6M
Armes Joseph B
FILED 2026-07-15
$434.9K
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
SouthernSun Small Cap Fund
$10.4M POSITION · AS OF 2026-03-31
4.3%
TAX MANAGED SMALL CAP PORTFOLIO
$6.4M POSITION · AS OF 2026-04-30
3.5%
Eaton Vance Small-Cap Fund
$4.2M POSITION · AS OF 2026-03-31
3.3%
Calvert Small Cap Fund
$48.5M POSITION · AS OF 2026-03-31
3.2%
Calvert Small/Mid-Cap Fund
$6.1M POSITION · AS OF 2026-03-31
3.1%
Calvert VP SRI Mid Cap Portfolio
$660.8K POSITION · AS OF 2026-03-31
3.1%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Executive pay vs shareholder return
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2025
$7.3M
$1.0M
$1.6M
+94%
+66%
2024
$6.3M
$17.7M
$1.7M
+116%
+26%
2023
$6.0M
$24.8M
$1.7M
+74%
+34%
2022
$4.3M
$9.4M
$1.4M
+3%
+1%
2021
$17.0M
$12.5M
$1.5M
-13%
-2%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2026-032025-032024-032023-03
REVENUE$1.1B$878.3M$792.8M$757.9M
GROSS PROFIT$453.7M$393.3M$350.7M$318.2M
OPERATING INCOME$168.5M$181.2M$159.1M$139.1M
NET INCOME$112.0M$136.7M$102.5M$96.6M
EPS (DILUTED)6.708.386.526.20
OPERATING CASH FLOW$149.7M$168.4M$164.3M$121.5M
CASH$33.8M$225.8M$22.2M$18.5M
LONG-TERM DEBT$839.8M$0$166.0M$253.0M
BUYBACKS$132.7M$27.7M$15.3M$39.1M
DIVIDENDS PAID$18.0M$14.6M$11.8M$10.6M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →